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Abstract
Background: In the clinical context, samples assayed by microarray are often classified by cell line
or tumour type and it is of interest to discover a set of genes that can be used as class predictors.
The leukemia dataset of Golub et al. [1] and the NCI60 dataset of Ross et al. [2] present multiclass
classification problems where three tumour types and nine cell lines respectively must be identified.
We apply an evolutionary algorithm to identify the near-optimal set of predictive genes that classify
the data. We also examine the initial gene selection step whereby the most informative genes are
selected from the genes assayed.
Results: In the absence of feature selection, classification accuracy on the training data is typically
good, but not replicated on the testing data. Gene selection using the RankGene software [3] is
shown to significantly improve performance on the testing data. Further, we show that the choice
of feature selection criteria can have a significant effect on accuracy. The evolutionary algorithm is
shown to perform stably across the space of possible parameter settings – indicating the robustness
of the approach. We assess performance using a low variance estimation technique, and present
an analysis of the genes most often selected as predictors.
Conclusion: The computational methods we have developed perform robustly and accurately,
and yield results in accord with clinical knowledge: A Z-score analysis of the genes most frequently
selected identifies genes known to discriminate AML and Pre-T ALL leukemia. This study also
confirms that significantly different sets of genes are found to be most discriminatory as the sample
classes are refined.
Background
Microarray technology has provided biologists with the
ability to measure the expression levels of thousands of
genes in a single experiment. The vast amount of raw gene
expression data leads to statistical and analytical chal-
lenges including the classification of the dataset into cor-
rect classes. The goal of classification is to identify the
differentially expressed genes that may be used to predict
class membership for new samples. The central diffculties
in microarray classification are the availability of a very
small number of samples in comparison with the number
of genes in the sample, and the experimental variation in
measured gene expression levels. While very effective
methods for binary classification (i.e. classification into
two classes) are known, these methods do not necessarily
perform as well in the multi-class case [4]. This paper
addresses the multi-class classification of microarray data,
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and the evaluation issues that arise in determining the
validity of the performance measures.
The classification of gene expression data samples
involves feature selection and classifier design. Feature
selection identifies the subset of differentially-expressed
genes that are potentially relevant for distinguishing the
classes of samples. The aim is to reduce the initial gene
pool from 7,000–10,000 to 100–200. Several gene selec-
tion methods based on statistical analysis have been
developed to select these predictive genes, they include t-
statistics, information gain, twoing rule, the ratio of
between-groups to within-groups sum of squares (BSS/
WSS) and principal component analysis [4,5]. In this
study we explore the alternative methods provided by the
RankGene software [3] for the initial feature selection
task.
Both supervised and unsupervised classifiers have been
used to build classification models from microarray data.
This study addresses the supervised classification task
where data samples belong to a known class. Many classi-
fiers have been used for this task such as Fisher Linear Dis-
crimination Analysis, Maximum Likelihood Discriminant
Rules, Classification Tree, Support Vector Machine (SVM),
K Nearest Neighbour (KNN), and aggregated classifiers
[4]. In this study we adopt the KNN classifier. KNN classi-
fication is based on a distance function such as the Eucli-
dean distance or Pearson's correlation that is computed
for pairs of samples in N-dimensional space. Each sample
is classified according to the class memberships of its k
nearest neighbours, as determined by the distance func-
tion. KNN has the advantages of simple calculation and
the ability to perform well on data sets that are not line-
arly separable, often giving better performance than more
complex methods in many applications (e.g. [4]). The aim
of this study is to evaluate an evolutionary algorithm for
multiclass classification of microarray samples by assess-
ing its classification accuracy on microarray samples. We
also investigate the feature selection step that is a neces-
sary precursor to classification. These objectives require an
appropriate evaluation method to determine the final fig-
ures for accuracy. Once the appropriate parameters for the
evolutionary algorithm are determined, its performance is
evaluated again using the .632 bootstrap estimation
method to obtain a low-variance measure. Two published
microarray datasets are used to test the performance of the
algorithms, namely, the leukemia and NCI60 datasets.
The contributions of this paper are: a comprehensive eval-
uation of an evolutionary classifier; an investigation of
feature selection in learning classifiers; an analysis of fre-
quently selected genes, and a comparison of gene rank-
ings across several previous studies of the leukemia data.
Systems and methodology
Evolutionary algorithm
Evolutionary algorithms have been applied to microarray
classification in order to search for the optimal or near-
optimal set of predictive genes on complex and large
spaces of possible gene sets. Evolutionary algorithms are
stochastic search and optimisation techniques that have
been developed over the last 30 years. These algorithms
are based on the same principles of evolution found in the
biological world involving natural selection, and survival
of the fittest. Evolutionary algorithms differ from other
traditional optimisation techniques in that they involve a
parallel search through a population of solutions.
The evolutionary algorithm we employ maintains a pop-
ulation of predictors whose effectiveness as a classifier can
be determined by using them as features in a KNN classi-
fier. The size of the population and the number of features
in a predictor are parameters that we shall explore experi-
mentally in the following section.
We assume that an initial gene pool of informative genes
has been identified (GP). The initial predictors in the pop-
ulation are randomly constructed from the initial gene
pool as indicated in Figure 1. A predictor contains
between 10 and 50 genes and so defines a subset of the
features (genes) that are identified in the initial feature
selection step.
Each predictor is scored according to its ability to classify
the training data based on a leave-one-out cross validation
(LOOCV) analysis. The scoring function S in steps 3b and
3c in Figure 1 is the sum of the training samples that are
correctly classified in the LOOCV. That is, one of the sam-
ples is left out to be a pseudo test data, the classifier is built
based on all but the left out sample, and the score incre-
mented if the sample is correctly classified. The score is
incremented by an additional amount proportional to the
minimum separation of the clusters. The replication of a
particular predictor depends on how the mutation effects
the scoring function. The selection process uses a statisti-
cal replication algorithm. The predictors which have a
higher score after mutation survive in the next generation.
The termination condition is met when the all predictors
give similar score over a specific number of generations.
The most successful predictor is the one giving the fewest
errors on the training samples. To measure the perform-
ance of the algorithm, the best predictor is evaluated again
using test samples.
The parameters of the evolutionary algorithm are fixed as
follows: The probability that a predictor will be mutated
is set to 0.7. The probability of adding a new gene to the
predictor and the probability to delete a gene from any
random position in predictor are set to 0.5. This makesBMC Bioinformatics 2005, 6:148 http://www.biomedcentral.com/1471-2105/6/148
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adding a gene and deleting a gene equally probable. The
KNN classifier uses the Euclidean distance measure. When
surveying the performance for the population size and
feature size parameters we report the average of the accu-
racy rate over 10 trials.
The selection and evolution process is a modification of
the statistical replication algorithm described in Deutsch
[6]. The termination criteria is defined using both the
maximum number of generations and the criteria of no
improvement of maximum fitness value of the popula-
tion. The predictor with highest fitness will be the one that
contains the best subset of genes for the classification task.
Genetic algorithm
In order to confirm the conclusions drawn from the exper-
imental analysis, we repeat the classification task using a
different search algorithm – a standard genetic algorithm
(GA) – in combination with a k-nearest neighbour classi-
fier. The GA encodes a weight for each feature in a chro-
mosome, and maintains a population of chromosomes
which are combined using crossover, and modified by
mutation operators in a standard manner [7]. The GA
explores the space of weights for each feature using a 1 bit
representation, where the feature is assigned a weight of 0
or 1. In this configuration, the GA+KNN classifier per-
forms feature selection and hence is directly comparable
to the evolutionary algorithm. The GA was configured to
have 20 chromosomes and was run for 100 generations in
each trial.
Methodology
To investigate the initial feature selection step, and its
effect on classifier learning, we apply six of the feature
Evolutionary algorithm for multiclass classification Figure 1
Evolutionary algorithm for multiclass classification.BMC Bioinformatics 2005, 6:148 http://www.biomedcentral.com/1471-2105/6/148
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selection methods supported in the RankGene [3] soft-
ware. These techniques have been widely used either in
machine learning (e.g. information gain and Gini index)
or in statistical learning theory (e.g. twoing rule, max
minority, sum of variances). They quantify the effective-
ness of a feature by evaluating the strength of class predict-
ability when the prediction is made by splitting the full
range of expression of a given gene into two regions, the
high region and the low region. The split point is chosen
to optimise the corresponding measure. Feature selection
is performed using only the samples in the training data
set.
The evolutionary algorithm that we shall evaluate learns
the optimal subset of features that classify the data, based
on the initial set of selected features. In the trials reported
here, the evolutionary algorithm will stop when the score
of all predictors in the population give a standard devia-
tion of less than 0.01 for ten consecutive generations, or
the evolutionary algorithm reaches the maximum
number of generations (200).
Many evaluation methods has been investigated for
small-sample error estimation. Typically, a microarray
experiment provides a dataset of small size, and as a result
the most commonly used method for error estimation is
leave-one-out cross validation (LOOCV). The LOOCV
error rate estimator is a straightforward technique and
gives an almost unbiased estimator.
A comparison of various error estimation methods is pre-
sented in [8], these include the resubstitution estimator,
k-fold cross-validation, leave-one-out estimation, and
bootstrap methodology. These methods were tested with
many classifiers: linear discriminant analysis, 3-nearest-
neighbour, and decision trees. For over all performance,
the .632 bootstrap proved to be the best estimator in their
simulations, but the drawback of this method is the com-
putational cost in comparison to LOOCV. As LOOCV is
almost unbiased and is fast, it is acceptable to use it for
parameter analysis.
We investigate the performance of the feature selection
methods and evolutionary algorithm as follows:
• The evolutionary classifier is tested on the leukemia
dataset without the use of any feature selection method.
• The RankGene methods are employed, and performance
compared against the baseline and against each other for
the leukemia data.
• The GA-based classifier is evaluated on the leukemia
data to validate these results.
• The evolutionary classifier is tested on the leukemia and
NCI60 datasets.
• A ranking of frequently selected genes by Z-score is
obtained, and the performance of the top ranked genes as
a classifier is measured.
• The .632 bootstrap error estimator is applied using the
optimal parameters for all datasets.
Results
We begin by demonstrating that the performance of the
population of predictors improves on each iteration of the
evolutionary algorithm. Figure 2 shows the average scores
in each iteration from several trials. The graph shows that
the average score increases more rapidly over the first few
generations in comparison with the final generations. The
evolutionary algorithm typically converges and termi-
nates in less than 50 generations. The runs terminate on
different iterations depending upon when the termina-
tion condition is met.
In the baseline test, the evolutionary algorithm is run on
the entire set of genes (without applying any feature selec-
tion method) in order to obtain a baseline measure of
performance.
The baseline system is evaluated on the 7,070 genes of the
leukemia dataset. The initial predictors in population are
built by randomly selecting 10 genes to be an initial fea-
ture of the predictors. This means the evolutionary algo-
rithm has to search for 10 optimal predictive genes set
from the   possible subsets. Performance of
the predictors is evaluated using KNN classifier to deter-
mine the LOOCV on training samples. After the best pre-
dictor is found in each generation, it will be tested again
on test samples to give the performance based on an out-
of-sample estimation. The KNN classifier classifies each
sample in the test data using a database of all training
samples.
Table 1 reports the maximum and the average accuracy of
the baseline system on 38 training samples and 34 test
samples. The results show that the evolutionary algorithm
gives predictors with perfect classification on the training
samples but those predictors do not classify the test data
well. The average accuracy on test data is 68% at best while
the average accuracy on training data is up to 98%. Table
1 indicates that population size may be a more important
factor than feature size for the baseline system.
7070
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Building an informative initial gene pool by the RankGene 
software
We determine the best choice for the number of initial fea-
tures, i.e. the initial gene pool, to be 100 by experiment
(by exploring the performance of the classifier using the
information gain ranking method for feature selection).
Based on this result, the performance of the following six
ranking methods for a range of population and feature
sizes is investigated: R1. Information gain; R2. Twoing
rule; R3. Gini index; R4. Sum minority; R5. Max minority;
R6. Sum of variances. The details of each method can be
found at http://genomics10.bu.edu/yangsu/rankgene/.
Leukemia dataset
The parameters of the evolutionary classifier are evaluated
on the set of 38 training samples and the 34 test samples
of the leukemia data – as described in the original work.
We explore: population size {10, 30, 50} feature size {30,
50} and initial gene pool 100.
The classification results are summarised in table 2. When
a predictor with 100% accuracy is learned in one or more
of the test runs we indicate this by (*). Average accuracy
over ten trials lies in the range 92–98%. Using feature
selection, the accuracy on the test data is more than 19%
The average score in each iteration for several trails of the evolutionary algorithm on the leukemia dataset Figure 2
The average score in each iteration for several trails of the evolutionary algorithm on the leukemia dataset.
Table 1: The accuracy of the baseline system built by randomly selecting genes from 7,070 genes in the leukemia dataset.
Population size Feature size Training data [%] Test data [%]
Max Average Max Average
10 30 89.47 85.79 79.41 64.41
50 89.47 84.21 76.47 63.53
30 30 94.74 98.42 85.29 68.82
50 97.37 96.05 73.53 67.35
50 30 100.00 98.42 85.29 70.29
50 100.00 98.42 85.29 72.64BMC Bioinformatics 2005, 6:148 http://www.biomedcentral.com/1471-2105/6/148
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greater than that of the baseline system. For a given feature
selection method, the prediction accuracy on the test sam-
ples varies up to 3% across the range of parameter settings
surveyed. The choice of feature selection method contrib-
utes up to 5% for a given set of algorithm parameters.
Information gain consistently gives the best performance
on the leukemia dataset.
The results of the confirmation study are shown in table 3,
where feature selection improves accuracy by at least 27%:
The accuracy on the training data in the baseline system
(without feature selection) is 85.26% which is signifi-
cantly greater than the test accuracy of 67.06%. A variation
of 4.4% is observed in average accuracy across the Rank-
Gene methods. The best RankGene method is informa-
tion gain. In comparison with feature selection by
information gain, all other methods have a significantly
lower accuracy on the testing data than information gain,
while there are no differences in performance on the train-
ing data across the other RankGene methods.
NCI60 dataset
The aim of this investigation is to find the best parameters
and ranking method for the evolutionary classifier when
applied to the NCI60 data. The same range of parameters
is surveyed as for the leukemia data, and again the per-
formance of six feature selection methods is evaluated.
Due to the very small sample size of the NCI60 dataset, it
is not possible to divide the data into training and testing
sets. Thus, the accuracy of predictors in table 4 is given by
using the LOOCV error rate estimation on the whole data-
set. To get a more reliable performance of the evolutionary
algorithm on the NCI60 dataset, the .632 bootstrap esti-
mator will be used.
The best classification score on the NCI60 data is 76.23%,
and was obtained using information gain, with a popula-
tion and feature size of 30. No predictor learned in any
run of the system was able to classify all data 100%
correctly.
Discrimination method
The frequency of selection of the genes that are members
of the best predictor across 100 independent trials is
assessed in order to determine the reproducibility of the
results. If a gene is consistently preferentially chosen as a
member of a predictive set it would suggest that the gene
selection operation is reproducible – despite the random
initialisation.
Z-score analysis is one means to determine the signifi-
cance of the observed frequency of an event against that
which might have occurred by chance. This calculation
normalises the frequency with which each of the initial
Table 2: The average accuracy using out-of-sample prediction on the 34 leukemia test samples. The symbol (*) means that there is 
some perfect predictors found by the algorithm. The highest accuracy is written in bold.
Population size Feature size The accuracy of different rank methods on the Test data (out-of-sample) [%]
R1 R2 R3 R4 R5 R6
10 30 97.35* 95.29 93.82 92.94* 93.53 94.12
50 98.24* 95.59 94.71* 93.82 93.53 95.00
30 30 96.74* 92.65 94.41 95.00* 94.71 93.82
50 97.06* 95.00 95.00 93.82 95.30 93.82
50 30 97.35* 93.82 94.71* 92.06* 94.12* 93.82*
50 96.17 93.82 92.65 92.35 94.12 94.71
Abbreviations: R1. Information gain; R2. Twoing rule; R3. Gini index; R4. Sum minority; R5. Max minority; R6. Sum of variances.
Table 3: The average accuracy of the GA/KNN classifier using out-of-sample prediction on the 34 leukemia test samples.
The accuracy of different rank methods on the Test data (out-of-sample) [%]
Baseline R1 R2 R3 R4 R5 R6
67.06 98.24 95.29 93.82 95.00 94.71 95.00*BMC Bioinformatics 2005, 6:148 http://www.biomedcentral.com/1471-2105/6/148
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genes was selected in all predictors that classify the
training and test data perfectly [9]. The Z score can be cal-
culated using equation (1).
Where  Si  denotes the number of times genes i  was
selected, E(Si) is the expected number of times for gene i
being selected, and σ  denotes the square root of the vari-
ance. The calculation of E(Si) is as follows: let A number
of perfect predictors found in the experiment, Pi  =
(number of genes) / (number of genes in the initial gene
pool). Then, E(Si) = Pi * A.
The evolutionary classifier was run 100 times on the
leukemia dataset using the best set of parameters: 100 ini-
tial genes constructed by the information gain and feature
size = 50. There are 43 predictors (ignoring the duplica-
tion) that classify all training and test data correctly. Fig-
ure 3 shows a plot of Z-score applied to the top ranked
genes that are most frequently selected. The top 24 genes
Table 4: The average accuracy on 5 sets of parameters and six ranking methods on the NCI60 data. No perfect predictors are found by 
the algorithm. The highest accuracy is written in bold.
Population size Feature size The accuracy of different rank methods on all dataset (LOOCV) [%]
R1 R2 R3 R4 R5 R6
10 30 66.72 63.77 60.00 54.43 62.78 69.34
50 67.86 62.78 61.63 52.62 62.62 65.90
30 30 76.23 72.29 72.02 65.90 74.26 75.41
50 73.44 72.46 71.15 63.11 73.44 73.93
50 50 75.08 72.29 71.96 71.97 73.77 74.16
A plot of Z-scores for 100 ranked genes on the leukemia dataset Figure 3
A plot of Z-scores for 100 ranked genes on the leukemia dataset.
Z
SE S ii =
− ()
()
σ
1BMC Bioinformatics 2005, 6:148 http://www.biomedcentral.com/1471-2105/6/148
Page 8 of 11
(page number not for citation purposes)
have a similar Z-score and the top 55 have a positive Z-
score. In this case, it seems reasonable to choose the 55
top-ranked gene as the most discriminative genes.
To confirm the predictive power of the 55 top-ranked
genes we constructed a classifier using these genes as fea-
tures. As before, we measure the accuracy on the test set
using the training set as a case-base. An accuracy of 100%
is obtained.
Additional file: 1 shows the 55 top-ranked genes, their fre-
quency of occurrence in the 43 best predictors and the Z-
score value. This set of genes will be used in the further
evaluation using .632 bootstrap estimator.
The Z-score analysis was repeated on the NCI60 data and
these results are shownin Figure 4. It can be seen that the
Z-score of the 8th ranked gene is half that of the top
ranked gene and that the top 40 genes have a positive Z-
score. Additional File 2 lists the top 40 genes. A classifier
constructed using these genes has an accuracy of 73.8% by
LOOCV, and 68.2% by a bootstrap estimate.
.632 bootstrap estimates
The .632 bootstrap method involves sampling the original
dataset (with replacement) to obtain a new resampled set
on which the classification error δ  is measured [8]. The
accuracy ε  on the samples omitted from the resampled set
is also determined. The bootstrap estimator ab632 for a
dataset of n samples requires n resampled datasets to be
constructed and the classification error calculated accord-
ing to equation (2). The final bootstrap estimate is the
average value of ab632 over b iterations of the procedure
(we take b = 200).
On the leukemia data, the .632 bootstrap estimate for the
accuracy of the evolutionary algorithm with population
size 10 and feature size 50 is 96.40%. The .632 estimate
for a classifier based on a fixed set of 55 top-ranked genes
is 96.85%.
On the NCI60 data, the .632 bootstrap estimate for the
accuracy of the evolutionary algorithm with population
size 30 and feature size 30, is 59.19%. The .632 estimate
for a classifier based on 40 top-ranked genes is 68.18%.
Discussion
On the data sets studied, we find that the evolutionary
algorithm performs robustly over the space of parameters
A plot of Z-scores for 100 ranked genes on the NCI60 dataset Figure 4
A plot of Z-scores for 100 ranked genes on the NCI60 dataset.
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surveyed. Optimal values for population size and feature
size are obtained, but the approach is not overly sensitive
to these choices. This is a promising result as stochastic
algorithms and techniques such as neural nets can be sen-
sitive to parameter settings [10].
Despite showing approximately 97% accuracy on the
leukemia data, the evolutionary algorithm does not per-
form as well on the NCI60 dataset. The .632 bootstrap
estimate of 59% for the NCI60 data is significantly less
than the 76% obtained by LOOCV. If we accept that the
bootstrap method is appropriate, then we must conclude
that the LOOCV estimates typically reported may be con-
siderable overestimates. The LOOCV estimate we obtain is
greater than the averages for the NCI60 data reported in
[4,5], but less than the best error rate reported in [11]. The
bootstrap estimate is comparable with the results of [5].
Gene selection
The value of the RankGene methods for feature selection
is shown by the improvement in accuracy over the base-
line results. Without feature selection, the evolutionary
algorithm can discover predictors that give 100% accuracy
on the training set, but perform poorly on the test set. A
similar finding is obtained using a GA-based search with
a KNN classifier. This indicates that the classes can be dis-
tinguished by any of a large set genes that are indicative of
a category, but that these genes are not necessarily inform-
ative in the sense that they are activated in a comparable
way across both the training and the testing sets. By
allowing uninformative genes into the feature set we
observe a degree of overfitting.
The correct choice of RankGene method can improve clas-
sification by 5% for a given population size and feature
size on the leukemia data (when using the evolutionary
algorithm). The confirmation study reproduced this find-
ing also. In comparison, the selection of population and
feature sizes can influence performance by up to 3% (for
a given RankGene method). Thus, feature selection has a
significant influence on the classifier learning task.
The optimal predictor
Several researchers have tried to find the optimal predic-
tive gene set. It has been suggested that for the leukemia
dataset the number of predictive genes included in a pre-
dictor should be less than 50 [12]. This conclusion was
based on a Z-score analysis. Deutsch [6] found an average
of 9 predictors was sufficient to classify the leukemia data
perfectly, with some runs reducing the number to 2. We
find 10 genes are not sufficient, and that that up to 55
genes are required, but have not attempted to identify a
lower bound.
Gene ranking
For comparison, the rankings of selected genes found to
be significant in previous analyses [13,14] of the leukemia
data are listed in Table 5 along with those ranked highly
by our methods. The ranking of Ben-Dor [13] is of genes
that discriminate between AML and ALL, while Thomas
[14] ranks the 25 genes more highly differentially
expressed genes in AML than in ALL, and provides a simi-
lar ranking for the genes differentially expressed in ALL.
Table 5 indicates that the genes that rank highly by differ-
ential expression lie outside of the top 15 in the rankings
that are derived to support classification, and some rank
outside of the top 30 (as indicated by a blank entry in the
table). For example, M23197, which is the human differ-
entiation antigen CD33 and a known indicator of
Table 5: Top ranking genes by Z-score (top 24 genes, this paper), by TNoM score (top 30 genes [13]1), and by differential expression in 
AML or in ALL (top 25 genes, [14]2). As the Z-score can give genes equal scores, a rank of 1 can be assigned to several genes. In our 
study 12 genes are ranked 1, in that of [13] 3 are ranked 1. The lowest place in a total ordering of the genes is indicated by figure in 
parenthesis, e.g. (≤ 12). Genes ranked in column 5 cannot appear in column 6, and vice versa, as indicated by (-). Otherwise, a blank 
entry indicates a ranking outside of the top 24, 25 or 30 genes respectively.
Gene Description Rank by Z-score Rank by TNoM1 Rank in AML2 Rank in ALL2
M23197 Myeloid cell surface antigen CD33 1 (≤ 12) 1 (≤ 3) 22 (≤ 22) -
X04145 T-cell surface glycoprotein CD3 1 (≤ 12)
M31211 Myosin light chain 1 (≤ 12) 6 (≤ 20) - 4 (≤ 4)
M31303 Leukemia-associated phosphoprotein 2 (≤ 13) 7 (≤ 32) - 11 (≤ 13)
U50136 Leukotriene C4 3 (≤ 24) 7 (≤ 32) 3 (≤ 3) -
M28170 B-lymphocyte surface antigen CD19 3 (≤ 24)
J04132 T-cell surface glycoprotein CD3 3 (≤ 24)
X95735 Zyxin 1 (≤ 3) 6 (≤ 6) -
M55150 Fumarylacetoacetate 6 (≤ 20) 1 (≤ 1) -
X59417 Proteasome iota chain 6 (≤ 20) - 3 (≤ 3)
U22376 C-myb -1  ( ≤ 1)BMC Bioinformatics 2005, 6:148 http://www.biomedcentral.com/1471-2105/6/148
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myeloid lineage [15], is ranked first the classification-
based scores but is 22nd in terms of differential
expression.
Only four of the top 24 genes we identify are found in the
50 genes listed as having highest relative differential
expression for AML/ALL respectively. In contrast, 14 of the
top 30 genes of Ben-Dor [13] are in this list (only a selec-
tion are tabulated here). This difference can be accounted
for by the fact that we address the 3-class problem while
Ben-Dor solve the 2-class problem. Thus it appears that
the differential expression of genes can be exploited in
classifying samples but, even in the 2-class case will, not
lead to optimal classification as it ignores the relation-
ships between the expression levels in a predictive set of
genes.
Five of the genes we rank in the top 3 (range 1–24 in terms
of a total ordering of genes) also lie in the equivalent
range (rank 1–6, or range 1–20 in a total ordering) in [13].
Further, the human CD19 antigen gene M28170 and T-
cell surface glycoproteins XO4145 and J04132 which are
ranked in the top 24 in our study do not appear in the top
50 genes in Ben-Dor [13] or in Thomas [14]. CD19 is
known to indicate B-lineage and CD3 to indicate T-line-
age [15] This study confirms that significantly different
sets of genes are found to be most discriminatory as the
sample classes are refined.
Conclusion
The evolutionary methods we have developed for micro-
array data classification perform robustly and accurately
on the data sets examined. The results are in accord with
clinical knowledge as demonstrated by a Z-score analysis
of the genes most frequently selected for inclusion in a
classifier: Genes known to discriminate between AML and
Pre-T ALL leukemia are identified. This study also con-
cludes that there are notable dependencies between the
way in which the classification problem is formulated and
the resulting rankings of discriminatory genes.
Methods
The 3-class leukemia dataset [1] and the 9-class tumour
NCI60 dataset [2] are used in this study. The leukemia
dataset is available at http://www.genome.wi.mit.edu/
MPR. In this dataset, gene expression levels were meas-
ured using Affymetrix high-density oligonucleotide arrays
containing 6,817 genes. The dataset consists of 47 sam-
ples of acute lymphoblastic leukemia(ALL) and 25 sam-
ples of acute myeloblastic leukemia(AML). Originally, the
dataset was built and analysed for binary classification:
ALL and AML. However, it can be separated into three or
four classes by using subtypes of ALL. To perform a multi-
class classification task, 72 samples in the dataset are
divided into three classes: ALL B-CELL(38), ALL T-
CELL(9), and AML(25). The training set is composed of
27 samples of ALL and 11 samples of AML, and the test set
is composed of 20 ALL and 14 AML samples. Golub et al.
[1] have normalised the dataset by re-scaling intensity val-
ues to make the overall intensities for each chip equiva-
lent and also fitted the data with a linear regression
model. From 7,129 genes, the baseline genes were cut off
before further analysis. The number of genes that are used
in the multiclass classification task is 7,070.
The NCI60 dataset is available at http://genome-
www.stanford.edu/sutech/download/nci60. This dataset
contains the gene expression profiles of 64 cancer cell
lines measured by cDNA microarrays and is provided
without normalisation. The gene expression data value is
the relative intensity level of the mRNA samples and their
references. The single unknown cell line and two prostate
cell lines were excluded from analysis due to their small
number. Nine classes of samples (61 cell lines) are identi-
fied: breast (7), central nervous system (5), colon (7),
leukemia (6), melanoma (8), non-small-cell-lung-carci-
noma or NSCLC (9), ovarian (6), renal (9) and reproduc-
tive (4). Excluding negative and missing values, the
number of genes considered is reduced from 9,703 to
7,375 genes.
Due to the noisy nature of the datasets resulting from
microarray experiments, preprocessing is an important
step. The NCI60 dataset has to be normalised to decrease
the variation before feature selection or classification.
Global normalisation is used to eliminate systematic var-
iance. For NCI60 dataset, the analysis of relative gene
expression level is done by using the log-ratios between a
certain gene (labelled in red or Cy5) and a reference gene
(labelled in green or Cy3) before the data is normalised.
The normalised values M are given by (3) where the con-
stant c is estimated from the mean for the log-ratio log2 (R/
G).
M = log2 (R/G) - c   (3)
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